These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10830785)

  • 41. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor.
    Wang X; McLennan SV; Allen TJ; Tsoutsman T; Semsarian C; Twigg SM
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1490-500. PubMed ID: 19625611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.
    Wang D; Oparil S; Feng JA; Li P; Perry G; Chen LB; Dai M; John SW; Chen YF
    Hypertension; 2003 Jul; 42(1):88-95. PubMed ID: 12756220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats.
    de Andrade EN; Gonçalves GK; de Oliveira TH; Santos CS; Souza CL; Firmes LB; de Magalhães AC; Soares Tde J; Reis AM; Belo Nde O
    Regul Pept; 2011 Feb; 167(1):149-55. PubMed ID: 21237215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corin-deficient W-sh mice poorly tolerate increased cardiac afterload.
    Buckley CL; Stokes AJ
    Regul Pept; 2011 Dec; 172(1-3):44-50. PubMed ID: 21903139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic metallothionein gene expression in toxic milk mice.
    Mercer JF; Grimes A; Rauch H
    J Nutr; 1992 Jun; 122(6):1254-9. PubMed ID: 1588441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling.
    Franco V; Chen YF; Oparil S; Feng JA; Wang D; Hage F; Perry G
    Hypertension; 2004 Nov; 44(5):746-50. PubMed ID: 15452027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
    Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
    Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy.
    Nozato T; Ito H; Watanabe M; Ono Y; Adachi S; Tanaka H; Hiroe M; Sunamori M; Marum F
    J Mol Cell Cardiol; 2001 Aug; 33(8):1493-504. PubMed ID: 11448137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.
    Li B; Chi RF; Qin FZ; Guo XF
    Exp Physiol; 2016 Aug; 101(8):1050-63. PubMed ID: 27219474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anemia plays a major role in myocardial hypertrophy of copper deficiency.
    Fields M; Lewis CG; Lure MD
    Metabolism; 1991 Jan; 40(1):1-3. PubMed ID: 1824601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats.
    Matsubara H; Yamamoto J; Hirata Y; Mori Y; Oikawa S; Inada M
    Circ Res; 1990 Jan; 66(1):176-84. PubMed ID: 2136812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.
    Qin F; Lennon-Edwards S; Lancel S; Biolo A; Siwik DA; Pimentel DR; Dorn GW; Kang YJ; Colucci WS
    Circ Heart Fail; 2010 Mar; 3(2):306-13. PubMed ID: 20018955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.
    Wang S; Gu J; Xu Z; Zhang Z; Bai T; Xu J; Cai J; Barnes G; Liu QJ; Freedman JH; Wang Y; Liu Q; Zheng Y; Cai L
    J Cell Mol Med; 2017 Jun; 21(6):1182-1192. PubMed ID: 28158919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low levels of ATP synthase and cytochrome c oxidase subunit peptide from hearts of copper-deficient rats are not altered by the administration of dimethyl sulfoxide.
    Chao JC; Medeiros DM; Davidson J; Shiry L
    J Nutr; 1994 Jun; 124(6):789-803. PubMed ID: 8207536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular biology and biochemistry of natriuretic peptide family.
    Ogawa Y; Itoh H; Nakao K
    Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):49-53. PubMed ID: 7768034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes.
    Cannon MV; Silljé HH; Sijbesma JW; Khan MA; Steffensen KR; van Gilst WH; de Boer RA
    Diabetologia; 2016 Mar; 59(3):634-43. PubMed ID: 26684450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
    Wang Y; Xing Y; Liu X; Chen L; Zhang G; Li Y
    Peptides; 2022 Nov; 157():170878. PubMed ID: 36108979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metallothionein inhibits ischemia-reperfusion injury in mouse heart.
    Kang YJ; Li G; Saari JT
    Am J Physiol; 1999 Mar; 276(3):H993-7. PubMed ID: 10070084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natriuretic peptide expression in the heart of the TTR-ANP transgenic mouse-Comparison to the normal heart.
    Lundberg S; Hansson M
    Microsc Res Tech; 2005 Oct; 68(2):97-106. PubMed ID: 16228981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
    Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.